title: [Advances in arterial hypertension and diabetes mellitus].
abstract: In 2011, the importance of hypertension and diabetes mellitus as the two main risk factors responsible for the development of cardiovascular disease became clear, as did their significance as major public health issues. Compared with previous years, in which publication of the results of large clinical trials dominated scientific progress, in the last year, the focus has shifted to evidence that novel mechanisms associated with blood pressure, glucose metabolism and diabetes can influence cardiovascular disease. Of particular importance were clinical trials in the area of renal dysfunction, such as the SHARP and ROADMAP trials.
authors.affiliation: Departamento de Cardiología, Hospital Universitario de San Juan, Alicante, España. acorderofort@gmail.com
authors.forename: Alberto
authors.initials: A
authors.lastname: Cordero
authors.forename: Iñaki
authors.initials: I
authors.lastname: Lekuona
authors.forename: Enrique
authors.initials: E
authors.lastname: Galve
authors.forename: Pilar
authors.initials: P
authors.lastname: Mazón
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000453:epidemiology*; D003928:Diabetic Nephropathies / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000453:epidemiology* / Q000517:prevention & control*; D007674:Kidney Diseases / Q000150:complications / Q000453:epidemiology; D011634:Public Health; D012307:Risk Factors